Efficiently Translate Efficacy and Safety to Humans
Questions Biosimulation Can Answer
- What efficacy, dosing, and toxicity can you expect when moving from preclinical investigation to humans?
- What are the best lead candidates for PK/PD studies?
- What are the risks for a candidate in healthy and diseased populations?
- What insight can you get from past preclinical or clinical data?
- What candidates should you in-license?
http://monologue.men canadian online pharmacies